|
|
GENERAL COURSE DESCRIPTION
Drug and alcohol addiction has become rampant across the globe. War, once the most common topic in the news and magazines, has taken a backseat to the celebrity body count associated with alcohol and drug addiction. The victims of this disease grow younger every year, and the drugs of choice expand on what seems like a daily basis.
This introductory course incorporates articles that review the basic elements of identification, assessment, diagnosis, and treatment for alcohol and drug abuse and addiction. The first set of articles review basic information about the most popular classes of drugs of choice. The second set of articles summarizes information about alcoholism and its treatment. The third set of articles present a variety of treatment interventions and protocols for drug addiction and the fourth set articulates the pro and con arguments on the hotly debated topic of the legalization of drugs. Finally, resources are provided for both the general public and the clinician.
|
|
Educational Objectives:
This course will teach psychotherapists to
- Identify a variety of drugs and addictive substances
- Compare and contrast mechanisms and qualities of different drugs of choice
- Summarize assessment tools used with those who are chemically dependent
- Describe a variety of treatments for alcohol and drug abuse and addiction
Course Syllabus:
- Identification
- Drugs of Choice: The big, the bad, and the ugly
- Cannabis
- Marijuana (“pot”, “weed”, “grass”, “ganja”, “skunk”, “maryjane”)
- Hashish (“hash”, “thai stick”)
- Hash Oil
- Stimulants
- Cocaine
- Crack
- Amphetamines (‘Speed”)
- Methamphetamine (“Ice”, “Crank”)
- Caffeine
- Nicotine
- Anabolic Steroids
- Hallucinogens
- LSD (“Acid”)
- Psilocybin & Psilocyn and other Tryptamines (“Mushrooms”)
- Peyote & Mescaline
- New Hallucinogens
- MDA
- MDMA (“Ecstasy”)
- PCP (“Angel Dust”)
- Ketamine
- Opiates & Narcotics
- Natural
- Opium
- Morphine
- Codeine
- Thebaine
- Semi-synthetic
- Heroin
- Hydromorphone
- Oxycodone
- Hydrocodone
- Synthetic
- Meperidine
- Dextropropoxyphene
- Fentanyl
- Pentazocine
- Butorphanol
- Narcotics used in treatment
- Methadone
- LAAM
- Buprenorphine
- Prescription Drugs
- Depressants
- Barbiturates
- Benzodiazepines
- Flunitrazepam
- Gamma Hydroxybutyric Acid
- Paraldehyde
- Chloral Hydrate
- Glutethimide and Methaqualone
- Meprobamate
- Newly Marketed Drugs
- Inhalants
- Hair spray, gasoline, spray paint
- Alcohol
- Assessment & Diagnosis
- What constitutes chemical dependency?
- Is there a difference between abuse and dependence?
- How do you assess the difference?
- Treatment
- Community Support & Intervention
- Outpatient Treatment
- Intensive Outpatient Programs
- Inpatient Treatment
- Pharmaceutical Interventions
- Integrative Medical Protocols
- Intervention
- Resources for clinicians, family and significant others
For Author's Bio, Click Here.
|
|
|
To receive clinical and practice updates, add your name to our confidential e-mail list.
CLICK HERE
Online Courses
Live Workshops -
Forensic & Expert Witness Services -
Consultations for Therapists
Private Practice Handbook -
HIPAA Compliance Kit -
Clinical Forms -
Home Study Courses -
CE Info
Online Catalog -
Free Articles -
Boundaries & Dual Relationships -
General Public Resources -
Articles For General Public
Home -
Contact Us -
About Us -
FAQ -
Privacy, Disclaimer - Terms of Use -
ADA Policy & Grievance -
CV -
Site Map
ZUR INSTITUTE, LLC
Ofer Zur, Ph.D., Director
|
Sonoma Medical Plaza, 181 Andrieux Street, Suite 212, Sonoma, CA 95476
Phone: 707-935-0655, Fax: 707-935-3918, E-mail: info@zurinstitute.com
|
| |
|
© 1997-2008 Zur Institute, LLC. All rights reserved. Privacy Statement, Disclaimer & Terms of Use Site design/maintenance by R&D Web
|
|
 |
